517 related articles for article (PubMed ID: 29280743)
1. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
[TBL] [Abstract][Full Text] [Related]
3. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
Mantovani G; Elli FM; Spada A
Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
[TBL] [Abstract][Full Text] [Related]
4. Pseudohypoparathyroidism type Ib in 2015.
Mantovani G; Elli FM
Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
[TBL] [Abstract][Full Text] [Related]
5. The GNAS locus and pseudohypoparathyroidism.
Bastepe M
Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
[TBL] [Abstract][Full Text] [Related]
6. Genetics and epigenetics of parathyroid hormone resistance.
Bastepe M
Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091
[TBL] [Abstract][Full Text] [Related]
7. GNAS locus and pseudohypoparathyroidism.
Bastepe M; Jüppner H
Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
[TBL] [Abstract][Full Text] [Related]
9. Inactivating PTH/PTHrP Signaling Disorders.
Mantovani G; Elli FM
Front Horm Res; 2019; 51():147-159. PubMed ID: 30641531
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of two cases of pseudohypoparathyroidism (ia and ib) and molecular analysis of GNAS].
Domínguez García A; Castaño González LA; Pérez-Nanclares G; Quinteiro González S; Caballero Fernández E
An Pediatr (Barc); 2013 Nov; 79(5):319-24. PubMed ID: 23623851
[TBL] [Abstract][Full Text] [Related]
11. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs).
Elli FM; Pereda A; Linglart A; Perez de Nanclares G; Mantovani G
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):941-954. PubMed ID: 30665554
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.
De Sanctis L; Romagnolo D; Olivero M; Buzi F; Maghnie M; Scirè G; Crino A; Baroncelli GI; Salerno M; Di Maio S; Cappa M; Grosso S; Rigon F; Lala R; De Sanctis C; Dianzani I
Pediatr Res; 2003 May; 53(5):749-55. PubMed ID: 12621129
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
[TBL] [Abstract][Full Text] [Related]
17. A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.
Brancatella A; Mantovani G; Elli FM; Borsari S; Marcocci C; Cetani F
Endocrine; 2020 Feb; 67(2):466-472. PubMed ID: 31939093
[TBL] [Abstract][Full Text] [Related]
18. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
[TBL] [Abstract][Full Text] [Related]
19. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.
Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B
J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
